Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper.

Creative Commons License

Klimek L., Jutel M., Bousquet J., Agache I., Akdis C. A., Hox V., ...More

Allergy, vol.76, pp.677-688, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 76
  • Publication Date: 2021
  • Doi Number: 10.1111/all.14629
  • Journal Name: Allergy
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.677-688
  • Keywords: biologics, chronic rhinosinusitis, COVID-19, CRSwNP, SARS-CoV-2, ENDOSCOPIC SINUS SURGERY, NASAL POLYPOSIS, ALLERGIC RHINITIS, GERMAN SOCIETY, ASTHMA, CORTICOSTEROIDS, EXACERBATIONS, ASSOCIATION, INTOLERANCE, PREVALENCE
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

BackgroundChronic rhinosinusitis is regarded as a chronic airway disease. According to WHO recommendations, it may be a risk factor for COVID-19 patients. In most CRSwNP cases, the inflammatory changes affecting the nasal and paranasal mucous membranes are type-2 (T2) inflammation endotypes.